F Wolter

423 total citations
18 papers, 335 citations indexed

About

F Wolter is a scholar working on Immunology, Hepatology and Epidemiology. According to data from OpenAlex, F Wolter has authored 18 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Hepatology and 6 papers in Epidemiology. Recurrent topics in F Wolter's work include Immune Cell Function and Interaction (9 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). F Wolter is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). F Wolter collaborates with scholars based in Germany, Spain and Slovakia. F Wolter's co-authors include Benjamin Krämer, Jacob Nattermann, Ulrich Spengler, A Glässner, P Kokordelis, Hans Dieter Nischalke, Jürgen K. Rockstroh, Christoph Boesecke, Marianne Eisenhardt and Klaus Lunau and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Hepatology.

In The Last Decade

F Wolter

18 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Wolter Germany 11 142 119 98 57 34 18 335
Sabine MacNelly Germany 8 138 1.0× 181 1.5× 36 0.4× 121 2.1× 39 1.1× 9 362
Joydip Bhanja Chowdhury United States 7 113 0.8× 161 1.4× 57 0.6× 151 2.6× 26 0.8× 7 333
Volker Schlüter Germany 7 304 2.1× 377 3.2× 46 0.5× 91 1.6× 45 1.3× 8 493
Tomokatsu Iwamura Japan 8 31 0.2× 111 0.9× 292 3.0× 143 2.5× 65 1.9× 11 481
Shipin Wu China 11 43 0.3× 67 0.6× 64 0.7× 143 2.5× 34 1.0× 18 288
Zhiming Huang China 13 150 1.1× 367 3.1× 43 0.4× 207 3.6× 88 2.6× 22 623
Shu Feng China 12 146 1.0× 189 1.6× 24 0.2× 131 2.3× 13 0.4× 26 374
Gennadiy Novitskiy United States 9 74 0.5× 124 1.0× 80 0.8× 122 2.1× 36 1.1× 9 428
Helena M. Daniels United Kingdom 8 201 1.4× 209 1.8× 66 0.7× 48 0.8× 29 0.9× 11 344

Countries citing papers authored by F Wolter

Since Specialization
Citations

This map shows the geographic impact of F Wolter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Wolter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Wolter more than expected).

Fields of papers citing papers by F Wolter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Wolter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Wolter. The network helps show where F Wolter may publish in the future.

Co-authorship network of co-authors of F Wolter

This figure shows the co-authorship network connecting the top 25 collaborators of F Wolter. A scholar is included among the top collaborators of F Wolter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Wolter. F Wolter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Vreman, Rick A., Anna Zawada, Giovanni Tafuri, et al.. (2020). Assessment of significant benefit for orphan medicinal products by European regulators may support subsequent relative effectiveness assessments by health technology assessment organizations. Drug Discovery Today. 25(7). 1223–1231. 14 indexed citations
3.
Kaczmarek, Dominik J., P Kokordelis, Benjamin Krämer, et al.. (2017). Alterations of the NK cell pool in HIV/HCV co-infection. PLoS ONE. 12(4). e0174465–e0174465. 12 indexed citations
4.
Krämer, Benjamin, Beatriz Sastre, Philipp Lutz, et al.. (2016). IL-28B Genetic Variants Determine the Extent of Monocyte-Induced Activation of NK Cells in Hepatitis C. PLoS ONE. 11(9). e0162068–e0162068. 4 indexed citations
5.
Goeser, Felix, A Glässner, P Kokordelis, et al.. (2015). HIV mono-infection is associated with an impaired anti-HCV activity of NK cells. AIDS. 1–1. 6 indexed citations
6.
Kokordelis, P, Benjamin Krämer, Christoph Boesecke, et al.. (2015). CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C. JAIDS Journal of Acquired Immune Deficiency Syndromes. 70(4). 338–346. 14 indexed citations
7.
Wolter, F, A Glässner, Benjamin Krämer, et al.. (2015). Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection. Journal of Hepatology. 63(6). 1334–1344. 10 indexed citations
8.
Lutz, Philipp, Kenneth Pfarr, Hans Dieter Nischalke, et al.. (2015). The ratio of calprotectin to total protein as a diagnostic and prognostic marker for spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites. Clinical Chemistry and Laboratory Medicine (CCLM). 53(12). 2031–9. 35 indexed citations
9.
Eisenhardt, Marianne, A Glässner, F Wolter, et al.. (2014). CD27(+)CD56Bright natural killer cells may be involved in spontaneous clearance of acute hepatitis C in HIV-positive patients. AIDS. 28(13). 1879–1884. 7 indexed citations
11.
Krämer, Benjamin, A Glässner, F Wolter, et al.. (2014). TLR-activated monocytes express IFN-lambda receptor 1 and trigger IFN-gamma secretion of NK cells after stimulation with IFN-lambda. Zeitschrift für Gastroenterologie. 52(8). 1 indexed citations
12.
Glässner, A, Marianne Eisenhardt, P Kokordelis, et al.. (2013). Impaired CD4+ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients. Journal of Hepatology. 59(3). 427–433. 66 indexed citations
13.
Nischalke, Hans Dieter, Cordula Berger, Philipp Lutz, et al.. (2013). Influence of the CXCL1 rs4074 A Allele on Alcohol Induced Cirrhosis and HCC in Patients of European Descent. PLoS ONE. 8(11). e80848–e80848. 18 indexed citations
14.
Sauerbier, Sebastian, Ralf Gutwald, Margit Wiedmann‐Al‐Ahmad, et al.. (2013). Effect of Gabapentin-Lactam and Gamma-Aminobutyric Acid/Lactam Analogs on Proliferation and Phenotype of Ovine Mesenchymal Stem Cells. The International Journal of Oral & Maxillofacial Implants. 28(5). e230–e238. 5 indexed citations
15.
Körner, Christian, Katarina Riesner, Benjamin Krämer, et al.. (2012). TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients. BMC Cancer. 12(1). 85–85. 19 indexed citations
16.
Lunau, Klaus, et al.. (2009). Visual detection of diminutive floral guides in the bumblebee Bombus terrestris and in the honeybee Apis mellifera. Journal of Comparative Physiology A. 195(12). 1121–1130. 34 indexed citations
17.
Wolter, F. (2003). Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos. Carcinogenesis. 24(3). 469–474. 38 indexed citations
18.
Zech, Michael, F Wolter, & Hans J. Bohnert. (1981). A simple filtration device to study the interaction of RNA-polymerase with DNA. Cellular and Molecular Life Sciences. 37(5). 537–539. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026